Answers are grounded in this paper and cite their sources.
The combination of robotic-assisted MIDCAB and thoracoscopic AF ablation is a promising minimally invasive approach, but requires larger, multicenter studies with longer follow-up to confirm long-term benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Amédéo Anselmi (2022) conducted an editorial in Coronary artery disease and atrial fibrillation (n=23). Combined MIDCAB and thoracoscopic off-pump radiofrequency ablation of atrial fibrillation was evaluated on Procedural morbidity and 1-year results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: